Life Technologies Corp. v. AB Sciex Pte. Ltd.

803 F. Supp. 2d 270, 2011 U.S. Dist. LEXIS 91366, 2011 WL 3610651
CourtDistrict Court, S.D. New York
DecidedAugust 11, 2011
Docket11 Civ. 00325(RJH)
StatusPublished
Cited by17 cases

This text of 803 F. Supp. 2d 270 (Life Technologies Corp. v. AB Sciex Pte. Ltd.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Life Technologies Corp. v. AB Sciex Pte. Ltd., 803 F. Supp. 2d 270, 2011 U.S. Dist. LEXIS 91366, 2011 WL 3610651 (S.D.N.Y. 2011).

Opinion

MEMORANDUM OPINION AND ORDER

RICHARD J. HOLWELL, District Judge:

Defendant AB Sciex Pte. Ltd. (“AB Sciex”) is a trademark licensee seeking to avoid arbitration with its trademark licensors, plaintiffs Life Technologies Corp. (“Life Tech”) and Applied Biosystems LLC (“Biosystems”). Life Tech and Biosystems initiated arbitration pursuant to an arbitration clause in an asset purchase agreement (the “Purchase Agreement”) by which AB Sciex’s affiliate, defendant DH Technologies Development Pte. Ltd. (“DH Tech”) purchased Life Tech’s mass spectrometry business. That agreement also required the parties to execute, or cause their affiliates to execute, a trademark license agreement. Ultimately, Life Tech and Biosystems licensed the trademarks to AB Sciex through a license agreement (the “License Agreement”) that does not contain an arbitration clause. Life Tech and Biosystems have since commenced arbitration proceedings against AB Sciex and DH Tech arising out of AB Sciex’s use of the trademarks. AB Sciex now moves to enjoin those proceedings as to it, arguing that it is not a signatory to any agreement containing an arbitration clause and that its use of the trademarks is governed exclusively by the License Agreement. AB Sciex is estopped from avoiding arbitra *272 tion, however, because it knowingly exploited the direct benefits of the Purchase Agreement by obtaining and using the licenses provided by the License Agreement. Accordingly, AB Sciex’s motion to enjoin the arbitration proceedings is DENIED.

BACKGROUND

The facts in this case are set forth in detail in the Court’s opinion denying plaintiffs’ motion for a preliminary injunction, Life Technologies Corp. v. AB Sciex Pte. Ltd., No. 11 Civ. 325, 2011 WL 1419612, at *1-4 (S.D.N.Y. Apr. 11, 2011), familiarity with which is assumed. The Court recounts the facts only as relevant to this motion.

In 2009 Life Tech transacted to sell its mass spectrometry business to Danaher Corporation (“Danaher”), an affiliate of defendant DH Tech. On September 2, 2009, Life Tech, Danaher, and DH Tech signed the Purchase Agreement laying out the terms of the sale. (See generally Szekeres Decl. Ex. A.) The Purchase Agreement, by which DH Tech bought Life Tech’s mass spectrometry business for roughly $450 million, required that “[o]n or prior to the Closing (but subject to the Closing being consummated), (i) [DH Tech] shall, and shall cause its respective Affiliates 1 to, execute and deliver to [Life Tech] copies of the Ancillary Agreements to which such Person is a party....” (Id. § 7.8; see also id. § 4.2(a)(v), (b)(iv) (requiring the parties to deliver the Ancillary Agreements at Closing); Szekeres Decl. ¶ 11.)

The Purchase Agreement also contained a detailed section on dispute resolution. As relevant to the present motion, the parties agreed therein that

in the event of any dispute, controversy or claim arising out of, relating to or in connection with this Agreement or any other Transaction Document ... or the breach, termination or validity thereof or the negotiation, execution or performance thereof (a “Dispute”), the parties shall attempt to settle such Dispute in the first instance by mutual discussions between representatives of senior management of each party.

(Id. § 11.6(a).) Should a Dispute prove irresolvable through negotiation, then the dispute “shall be submitted to mediation in accordance with the JAMS International Mediation Rules.” (Id. § 11.6(b).) In turn, “[a]ny Dispute not timely resolved in accordance with Section 11.6(b) shall be finally and exclusively resolved by arbitration in accordance with the then-prevailing JAMS International Arbitration Rules and Procedures....” (Id. § 11.6(c).) The Transaction Documents referred to in Section 11.6(a) included the Purchase Agreement and all Ancillary Agreements. (Id. § 1.1 (defining “Transaction Documents”).)

One of the Ancillary Agreements was the License Agreement. (Id. § 1.1 (defining “Ancillary Agreements”).) Life Tech and Biosystems executed that agreement with AB Sciex, a DH Tech affiliate, on January 29, 2010, the closing date of the Purchase Agreement. (See generally Szekeres Decl. Ex. B; Szekeres Decl. ¶ 10.) The agreement’s recitals noted the Purchase Agreement “whereby [DH Tech] has agreed to purchase, or cause affiliates to purchase, certain assets of [Life Tech and Biosystems] relating to [Life Tech and Biosystem’s] Mass Spec Business and Consumables Business.” (License Agreement at 1.) The recitals concluded, “NOW *273 THEREFORE, in consideration of the mutual promises and covenants set forth herein and in the [Purchase Agreement], the parties, intending to be legally bound, hereto agree.” (Id.)

In the License Agreement, Life Tech and Biosystems granted AB Sciex licenses to use certain trademarks in certain manners. Specifically, Life Tech and Biosystems granted AB Sciex (1) “a non-exclusive, limited worldwide, royalty-free and fully paid-up license” to use one set of marks; and (2) “an exclusive (even as to [Life Tech and Biosystems]), perpetual, worldwide, royalty-free and fully paid-up license” to use another set of marks. (Id. §§ 2.1, 2.2.) Both licenses were subject to certain limitations explained in detail in the License Agreement. (Id. §§ 2.1-2.8, 3.5.) The parties also “agree[d] that no additional consideration is owed or due to [Life Tech and Biosystems] for the rights granted to [AB Sciex] hereunder.” (Id. § 2.9.)

The License Agreement lacks a section explicitly addressing conflict resolution procedures, but does state (1) that the agreement “and any other writing signed by the parties that specifically references this Agreement constitute the entire agreement among the parties with respect to the subject matter hereof and supersede all prior agreements, understandings ... both written and oral, between the parties with respect to the subject matter hereof,” (id. § 9.1); and (2) that AB Sciex “acknowledges that monetary relief would not be an adequate remedy for a breach ... and that [Life Tech and Biosystems] shall be entitled to the enforcement of this Agreement by injunction, ... without prejudice to any other rights and remedies ....” (id § 9.4).

On January 18, 2011, plaintiffs brought this suit asserting claims for, inter alia, breach of contract pursuant to the License Agreement, trademark infringement, and related claims against AB Sciex, and breach of contract pursuant to the Purchase Agreement against DH Tech, and sought a preliminary injunction. The Court subsequently denied plaintiffs’ motion for a preliminary injunction.

On April 22, 2011, Life Tech and Biosystems filed a demand for arbitration with JAMS, naming both DH Tech and AB Sciex as respondents. (Szekeres Decl. ¶ 12; see also Szekeres Decl. Ex. C at 2, 5.) AB Sciex now moves to enjoin the arbitration as against it, arguing primarily that it never signed any agreement to arbitrate with Life Tech or Biosystems.

DISCUSSION

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mars Incorporated v. Szarzynski
District of Columbia, 2021
Gater Assets Ltd. v. AO Moldovagaz
2 F.4th 42 (Second Circuit, 2021)
HEALTHPLANCRM, LLC v. AVMED, INC.
W.D. Pennsylvania, 2020
Matter of KPMG LLP v. Kirschner
2020 NY Slip Op 2286 (Appellate Division of the Supreme Court of New York, 2020)
Wta Tour, Inc. v. Super Slam Ltd.
339 F. Supp. 3d 390 (S.D. Illinois, 2018)
Boroditskiy v. European Specialties LLC
314 F. Supp. 3d 487 (S.D. Illinois, 2018)
Katsoris v. WME IMG, LLC
237 F. Supp. 3d 92 (S.D. New York, 2017)
Trina Solar US, Inc. v. JRC-Services LLC
229 F. Supp. 3d 176 (S.D. New York, 2017)
BGC Notes, LLC v. Gordon
142 A.D.3d 435 (Appellate Division of the Supreme Court of New York, 2016)
Chesapeake Appalachia v. Cecil L. HIckman, etc.
781 S.E.2d 198 (West Virginia Supreme Court, 2015)
Gilman v. Walters
61 F. Supp. 3d 794 (S.D. Indiana, 2014)
In re A2P SMS Antitrust Litigation
972 F. Supp. 2d 465 (S.D. New York, 2013)
Personal Communications Devices, LLC v. HTC America Inc.
40 Misc. 3d 790 (New York Supreme Court, 2013)
LaRoss Partners, LLC v. Contact 911 Inc.
874 F. Supp. 2d 147 (E.D. New York, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
803 F. Supp. 2d 270, 2011 U.S. Dist. LEXIS 91366, 2011 WL 3610651, Counsel Stack Legal Research, https://law.counselstack.com/opinion/life-technologies-corp-v-ab-sciex-pte-ltd-nysd-2011.